Clinical trial
Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel…
NCT00376896 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00376896 |
|---|---|
| Title | Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers |
| Official title | A Phase IIa Experimental Medicine Study Assessing Alterations in Regional Cerebral Blood Flow by Functional Magnetic Resonance Imaging (fMRI) in Female IBS Patients and Healthy Controls Following Single Doses of GW876008, a Corticotrophin Releasing Factor 1 Receptor Antagonist (CRF1-RA) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Irritable Colon, Irritable Bowel Syndrome (IBS) |
| Intervention type | Drug, Other |
| Interventions | GW876008 200mcg, GW876008 20mcg, Placebo |
| Enrollment | 25 |
| Start date | Nov 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Sep 15, 2006 |
| Last update posted | May 16, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: